Genesis 2026 - L07: From Theory to Practice: Aptadir Therapeutics - Giovanni Amabile

​We are pleased to welcome Giovanni Amabile to the seventh session of Genesis 2026, a special case-study into the story behind Aptadir Therapeutics. Giovanni is a co‑founder of Aptadir, a biotech company developing innovative RNA‑based targeted therapeutics designed to address diseases with high unmet medical needs. Drawing on his experience in both scientific research and startup creation, he has played a central role in moving the company from concept to operational growth.

​In this session, Giovanni will walk through the key milestones and decisions that shaped Aptadir’s path. The participants will gain practical insights into the challenges and opportunities of launching a life sciences venture, learning directly from an entrepreneur who has navigated the transition from research idea to a functioning biotech startup.